{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:50:08Z","timestamp":1784994608296,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Alberta"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Patients with mitochondrial diseases can develop cardiomyopathy but with variable expressivity and penetrance. Our prospective study enrolled and evaluated a cohort of 53 patients diagnosed with chronic progressive ophthalmoplegia (CPEO, n = 34), Kearns\u2013Sayre syndrome (KSS, n = 3), neuropathy ataxia and retinitis pigmentosa (NARP, n = 1), myoclonic epilepsy with ragged red fibers (MERRF, n = 1), Harel\u2013Yoon Syndrome (HYS, n = 1) and 13 patients with undefined mitochondrial diseases, presenting primarily with neurological symptoms. Over a 4-year period, six patients in our study cohort were diagnosed with heart disease (11.3%), with only three patients having defined cardiomyopathy (5.7%). Cardiomyopathy was present in a 21-year-old patient with HYS and two CPEO patients having mild cardiomyopathy at an older age. Two CPEO patients had congenital heart disease, and a third CPEO had LV hypertrophy secondary to hypertension. In three patients, traditional risk factors for heart disease, including dyslipidemia, hypertension, and respiratory disease, were present. The majority of our adult cohort of patients have normal cardiac investigations with a median left ventricular (LV) ejection fraction of 59.0%, indexed LV mass of 67.0 g\/m2, and normal diastolic and valvular function at baseline. A 12-lead electrocardiogram showed normal cardiac conduction across the study cohort. Importantly, follow-up assessments showed consistent cardiac structure and function. Our study shows a low prevalence of cardiomyopathy and highlights the breadth of phenotypic variability in patients with mitochondrial disorders. The presence of cardiovascular risk factors and aging are important comorbidities in our cohort.<\/jats:p>","DOI":"10.3390\/jcdd9070221","type":"journal-article","created":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:48:00Z","timestamp":1657493280000},"page":"221","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Low Prevalence of Cardiomyopathy in Patients with Mitochondrial Disease and Neurological Manifestations"],"prefix":"10.3390","volume":"9","author":[{"given":"Anish","family":"Nikhanj","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada"},{"name":"Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesi","family":"Bautista","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaeem A.","family":"Siddiqi","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile L.","family":"Phan","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-9028","authenticated-orcid":false,"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada"},{"name":"Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1873-3468.12956","article-title":"Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease","volume":"592","author":"Nissanka","year":"2018","journal-title":"FEBS Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.4809","article-title":"The genetics and pathology of mitochondrial disease","volume":"241","author":"Alston","year":"2017","journal-title":"J. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.aac7516","article-title":"Mutations causing mitochondrial disease: What is new and what challenges remain?","volume":"349","author":"Lightowlers","year":"2015","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.21037\/atm.2018.12.13","article-title":"Mitochondrial disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrg3966","article-title":"The dynamics of mitochondrial DNA heteroplasmy: Implications for human health and disease","volume":"16","author":"Stewart","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1093\/eurheartj\/ehv307","article-title":"Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases","volume":"36","author":"Wahbi","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","article-title":"Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects","volume":"91","author":"Anan","year":"1995","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2004-0718","article-title":"Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease","volume":"114","author":"Scaglia","year":"2004","journal-title":"Pediatrics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijcard.2006.07.121","article-title":"Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder","volume":"119","author":"Finsterer","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/eurjhf\/hfp186","article-title":"Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease","volume":"12","author":"Limongelli","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1212\/NXG.0000000000000339","article-title":"Systematic review and meta-analysis of cardiac involvement in mitochondrial myopathy","volume":"5","author":"Quadir","year":"2019","journal-title":"Neurol. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","article-title":"Cardiac involvement in mitochondrial DNA disease: Clinical spectrum, diagnosis, and management","volume":"33","author":"Bates","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10741-015-9524-5","article-title":"MELAS syndrome and cardiomyopathy: Linking mitochondrial function to heart failure pathogenesis","volume":"21","author":"Hsu","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0921-8734(92)90025-K","article-title":"Evidence for and against the causal involvement of mitochondrial DNA mutation in mammalian ageing","volume":"275","author":"Bittles","year":"1992","journal-title":"Mutat. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1474-4422(10)70116-2","article-title":"A neurological perspective on mitochondrial disease","volume":"9","author":"McFarland","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehv429","article-title":"Mitochondrial disorders with cardiac dysfunction: An under-reported aetiology with phenotypic heterogeneity","volume":"36","author":"Pankuweit","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_22","first-page":"e137","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Jessup","year":"2017","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","article-title":"Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy","volume":"181","author":"Kabunga","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0002-9149(79)90294-7","article-title":"The metabolic demand and oxygen supply of the heart: Physiologic and clinical considerations","volume":"44","author":"Weber","year":"1979","journal-title":"Am. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e001510","DOI":"10.1136\/openhrt-2020-001510","article-title":"Risk of cardiac manifestations in adult mitochondrial disease caused by nuclear genetic defects","volume":"8","author":"Lim","year":"2021","journal-title":"Open Heart"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cjca.2014.05.013","article-title":"Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease","volume":"30","author":"Mancini","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Apabhai, S., Gorman, G.S., Sutton, L., Elson, J.L., Pl\u00f6tz, T., Turnbull, D.M., and Trenell, M.I. (2011). Habitual physical activity in mitochondrial disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022294"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2018.12.064","article-title":"The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome-systematic review of the articles","volume":"279","author":"Imamura","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e12876","DOI":"10.1111\/anec.12876","article-title":"Clinical utility of 12-lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy","volume":"26","author":"Nikhanj","year":"2021","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5603\/CJ.a2018.0108","article-title":"The usefulness of selected biomarkers in aortic regurgitation","volume":"26","author":"Duchnowski","year":"2019","journal-title":"Cardiol. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ehjqcco\/qcaa059","article-title":"Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy","volume":"7","author":"Nikhanj","year":"2021","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e014004","DOI":"10.1161\/JAHA.119.014004","article-title":"Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients with Muscular Dystrophy in a Multidisciplinary Care Setting","volume":"9","author":"Nikhanj","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.amjcard.2019.08.039","article-title":"Comparison of Usefulness of Cardiac Resynchronization Therapy in Patients with Type 1 Myotonic Dystrophy with Versus without Left Bundle Branch Block","volume":"124","author":"Nikhanj","year":"2019","journal-title":"Am. J. Cardiol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/9\/7\/221\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:47:13Z","timestamp":1760140033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/9\/7\/221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jcdd9070221"],"URL":"https:\/\/doi.org\/10.3390\/jcdd9070221","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,9]]}}}